India News | Reported by Sreenivasan Jain, Edited by Deepshikha Ghosh | Monday August 2, 2021
The supply of Bharat Biotech's Covaxin has been slowed down because the first few batches at the company's newest facility in Bengaluru were not of the right quality, a top government adviser has said.
www.ndtv.com